Suven Life Sciences · NSE: SUVEN · BSE: 530239
Q2 FY19 results · Jul–Sep 2018
Suven Life Sciences reported revenue from operations of ₹89.52 crore and net profit of ₹18.01 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 89.52 | — | — | 191.66 | −53.3% |
| Other income | 6.59 | — | — | 8.13 | −19.0% |
| Total income | 96.11 | — | — | 199.79 | −51.9% |
| Profit before tax | 24.85 | — | — | 59.78 | −58.4% |
| Net profit for the period | 18.01 | — | — | 38.84 | −53.6% |
| EPS, basic (₹) | 1.41 | — | — | 3.05 | −53.8% |
| Net margin (%) | 20.1 | — | 20.3 |
Standalone
- Filed with BSE
- 20 Nov 2018, 18:23 IST
- Board meeting
- 14 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE